Pyxis Oncology, Inc. (PYXS)
NASDAQ·Healthcare·Biotechnology
$3.21
-1.53%
Mkt Cap $246.45M
Analyst Ratings
Buy
7
Hold
0
Sell
0
Price Target (9 analysts)
$6.50
Range $6.00 – $7.00
Implied Upside
+102.5%
Consensus $6.50 vs current $3.21
NASDAQ·Healthcare·Biotechnology
$3.21
-1.53%
Mkt Cap $246.45M
Buy
7
Hold
0
Sell
0
Price Target (9 analysts)
$6.50
Range $6.00 – $7.00
+102.5%
Consensus $6.50 vs current $3.21